Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Trastuzumab Injection

This product is suitable for HER2-positive metastatic breast cancer: as a single drug treatment for metastatic breast cancer that has received one or more chemotherapy regimens; combined with paclitaxel or docetaxel for patients with metastatic breast cancer who have not received chemotherapy.
Adjuvant therapy for breast cancer:
This product is suitable for adjuvant treatment of HER2-positive breast cancer after surgery, adjuvant chemotherapy containing anthracyclines, and radiotherapy (if applicable).
Metastatic gastric cancer:
This product combined with capecitabine or 5-fluorouracil and cisplatin is suitable for patients with HER2-positive metastatic gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have not received previous treatment for metastatic disease.


Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.